Illustrative image – not actual.Shantha Biotechnics Pvt Ltd plans to set up a multi-product biotech production facility at Madchal on the outskirts of Hyderabad in Andhra Pradesh. The facility would include a production unit for Hepatitis – B vaccine and a research and development laboratory.
The project, estimated to cost Rs.60
crore, is proposed to be funded through internal accruals and debt. The facility
would have four production lines. The company plans to introduce at least six
products in a period of 18 months, through the proposed facility. The company has
dropped its earlier plan of going in for an initial public offering, in view of
prevailing market conditions.
The Madchal locality is a part of the
Genome Valley area identified by the Andhra Pradesh government in its biotech
policy.
The company is looking out for an
international firm to take up the project on a turnkey basis as per the standards
of the US Food and Drug Administration.
